Outcomes | FDS | SCWT | WR | NWR | PD | TC | CW |
---|---|---|---|---|---|---|---|
Clinical measures | |||||||
 SCWT | − 0.28 (0.148) | – | – | – | – | – | – |
 WR | 0.70** (˂0.001) | −0.36* (0.045) | – | – | – | – | – |
 NWR | 0.61** (˂0.001) | − 0.13 (0.495) | 0.51** (0.005) | – | – | – | – |
 PD | 0.41* (0.027) | − 0.16 (0.410) | 0.46* (0.013) | 0.41* (0.028) | – | – | – |
 TC | 0.36 (0.056) | − 0.20 (0.301) | 0.34 (0.069) | 0.45* (0.015) | 0.47** (0.010) | – | – |
 CW | 0.60** (0.001) | − 0.25 (0.184) | 0.87** (˂0.001) | 0.41* (0.026) | 0.39* (0.038) | 0.35 (0.060) | – |
CoP measures | |||||||
 QO-L (cm) | − 0.25 (0.186) | 0.05 (0.814) | − 0.39* (0.035) | − 0.26 (0.167) | − 0.50** (0.006) | 0.01 (0.970) | − 0.26 (0.179) |
 QO-A (cm2) | − 0.52** (0.004) | 0.20 (0.303) | − 0.58** (0.001) | − 0.42* (0.024) | − 0.47* (0.010) | − 0.38* (0.045) | − 0.44* (0.017) |
 QO-MV (cm/s) | − 0.25 (0.187) | 0.05 (0.816) | − 0.39* (0.036) | − 0.26 (0.169) | − 0.50** (0.006) | 0.016 (0.936) | − 0.26 (0.181) |
 QO-AP (SD) | − 0.29 (0.130) | 0.15 (0.433) | − 0.42* (0.023) | − 0.18 (0.342) | − 0.33 (0.079) | − 0.22 (0.253) | − 0.35 (0.066) |
 QO-ML (SD) | − 0.60** (0.001) | 0.06 (0.739) | − 0.56** (0.002) | − 0.52** (0.004) | − 0.45* (0.014) | − 0.45* (0.015) | − 0.46* (0.011) |
 QC-L (cm) | − 0.18 (0.351) | 0.13 (0.495) | − 0.33 (0.077) | 0.06 (0.759) | − 0.18 (0.345) | 0.10 (0.618) | − 0.31 (0.106) |
 QC-A (cm2) | − 0.47** (0.010) | 0.17 (0.368) | − 0.26 (0.150) | − 0.16 (0.415) | − 0.25 (0.197) | − 0.04 (0.849) | − 0.26 (0.177) |
 QC-MV (cm/s) | − 0.20 (0.307) | 0.14 (0.486) | − 0.36 (0.053) | 0.05 (0.806) | − 0.19 (0.319) | 0.09 (0.647) | − 0.31 (0.107) |
 QC-AP (SD) | − 0.29 (0.125) | 0.31 (0.099) | − 0.31 (0.097) | − 0.16 (0.423) | − 0.55** (0.002) | − 0.21 (0.267) | − 0.29 (0.127) |
 QC-ML (SD) | − 0.41* (0.028) | − 0.17 (0.388) | − 0.22 (0.254) | − 0.15 (0.445) | − 0.00 (0.986) | 0.06 (0.744) | − 0.17 (0.380) |